Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition.
Diabetes mellitus, one of the most common endocrine-metabolic disorders, has caused significant morbidity and mortality worldwide. To avoid sugar digestion and postprandial hyperglycemia, it is necessary to inhibit α-glucosidase, a digestive enzyme with an important role in carbohydrate digestion. The criteria for the selection of alkaloids are based on their in vitro and in vivo activities on glucose modulation. The current study assessed the bonding potential of isolated alkaloids with the targeted protein. For this purpose, the 3D structure of the target protein (α-glucosidase) was reproduced using MODELLER 9.20. The modeled 3D structure was then validated and confirmed by using the RAMPAGE, ERRAT, and Verify3D online servers. The molecular docking of 32 alkaloids reported as α-glucosidase inhibitors, along with reference compounds (acarbose and miglitol), was done through MOE-Dock applied in MOE software to predict the binding modes of these drug-like compounds. The results revealed that nummularine-R and vindoline possess striking interactions with active site residues of the target protein, and were analogous to reference ligands. In conclusion, the current study provided a computational background to the α-glucosidase inhibitors tested. This novel information should facilitate the development of new and effective therapeutic compounds for the treatment of diabetes mellitus.
['Rahman|Noor|N|', 'Muhammad|Ijaz|I|', '|||', 'Khan|Haroon|H|', 'Aschner|Michael|M|', 'Filosa|Rosanna|R|', 'Daglia|Maria|M|']
D000470:Alkaloids D001665:Binding Sites D003920:Diabetes Mellitus D065089:Glycoside Hydrolase Inhibitors D006801:Humans D007004:Hypoglycemic Agents D008958:Models, Molecular D062105:Molecular Docking Simulation D000520:alpha-Glucosidases
molecular docking α-glucosidase new drug discovery plant alkaloids